Browse Category

Earnings Reports News 28 January 2026

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet stock jumps 11% after Q2 earnings beat and upbeat outlook lifts AVT price

Avnet shares jumped 11% to $58.65 by early afternoon Wednesday after quarterly earnings and a third-quarter forecast topped Wall Street estimates. The company reported fiscal Q2 sales of $6.319 billion and adjusted EPS of $1.05, beating analyst expectations. Arrow Electronics and TD SYNNEX also rose. Avnet projected Q3 sales of $6.20–$6.50 billion and adjusted EPS of $1.20–$1.30.
Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer stock drops as Medicare puts Xeljanz on 2028 price-talk list, earnings next week

Pfizer shares fell 1.8% to $26.02 after U.S. Medicare included Xeljanz in its upcoming drug price negotiations, set to begin in 2026 with prices effective in 2028. The Centers for Medicare & Medicaid Services named 15 drugs for talks, and companies must decide by February 28 whether to participate. Investors are awaiting Pfizer’s February 3 earnings for updates on pricing risks.
Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard stock price slips today as MA heads into earnings after Agent Suite AI rollout

Mastercard shares slipped 0.1% to $519.71 by midday Wednesday, trailing Visa’s gains ahead of Thursday’s earnings report. The company unveiled a new AI-driven “Agent Suite” Tuesday, aiming for a Q2 2026 launch. Cantor Fitzgerald initiated coverage with an Overweight rating and a $650 price target. Mastercard stock remains about 13.5% below its 52-week high.
Visa stock price ticks up on Redburn upgrade as earnings day nears

Visa stock price ticks up on Redburn upgrade as earnings day nears

Visa shares rose 0.2% to $325.90 Wednesday after Rothschild Redburn upgraded the stock to “Buy” and raised its price target to $385. Investors are positioning ahead of Visa’s fiscal Q1 results, due after Thursday’s close. Analyst coverage intensified, with Cantor Fitzgerald setting a $400 target. The company remains in a quiet period until results are released.
Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move

Lam Research stock price wobbles ahead of earnings as Wall Street braces for a big move

Lam Research shares fell 0.1% to $238.15 by midday, nearing session lows ahead of its quarterly earnings due after the close. Options traders expect a swing of about 7.9% in either direction following results. Analysts forecast earnings of $1.17 per share on $5.24 billion revenue. Mizuho raised its price target to $265, citing accelerating wafer fab equipment spending.
Amphenol stock price slides 11% after record results; investors wait on CCS details

Amphenol stock price slides 11% after record results; investors wait on CCS details

Amphenol shares fell 11% to $147.69 Wednesday despite reporting record Q4 sales of $6.4 billion and raising its Q1 outlook. The stock dropped $18.56 from its prior close, with 16.4 million shares traded. Investors focused on margins and IT datacom demand as the company integrates its CommScope CCS acquisition. Executives will address questions at a 1 p.m. ET call.
GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

GE Vernova stock wobbles after earnings as GEV lifts 2026 forecast but flags Vineyard Wind hit

GE Vernova raised its 2026 revenue forecast to $44–$45 billion and reported a $150 billion backlog, sending shares up 0.4% to $695.58 Wednesday. The company warned its wind division could lose $250 million in revenue this year due to Vineyard Wind delays. Fourth-quarter orders jumped 65% to $22.2 billion. GE Vernova’s acquisition of Prolec GE is set to close February 2.
Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

Banco Bradesco’s U.S.-listed shares edged up 0.1% Wednesday, hovering near a 52-week high as investors awaited Brazil’s central bank rate decision. January inflation hit 4.5%, matching the top of the target range, prompting traders to expect rates to hold steady. Bradesco will report fourth-quarter results Feb. 5. The bank renewed its agreement with payments firm Cielo.
Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer stock dips after Xeljanz lands on Medicare price-talk list, with earnings looming

Pfizer shares fell 1.7% to $26.06 after CMS selected its arthritis drug Xeljanz for Medicare price negotiations, with new prices set for 2028. Xeljanz accounted for about $1.01 billion in Medicare spending in the latest period. Investors await Pfizer’s Feb. 3 quarterly results and a Feb. 28 CMS deadline for drugmakers to sign participation agreements.
Boeing stock slips after earnings boost, cash-flow guide takes center stage

Boeing stock slips after earnings boost, cash-flow guide takes center stage

Boeing shares fell about 1% to $242 in morning trading after Q4 earnings were lifted by a $9.6 billion divestiture gain. Management reaffirmed a positive 2026 free cash flow outlook despite costs from the Spirit AeroSystems integration and a new KC-46 charge. Investors remain focused on 737 MAX production rates and delays in 777X certification. Fourth-quarter free cash flow reached $375 million.
1 67 68 69 70 71 336

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop